These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 28393582)

  • 1. Insights into the human brain proteome: Disclosing the biological meaning of protein networks in cerebrospinal fluid.
    Bastos P; Ferreira R; Manadas B; Moreira PI; Vitorino R
    Crit Rev Clin Lab Sci; 2017 May; 54(3):185-204. PubMed ID: 28393582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Essential Features and Use Cases of the Cerebrospinal Fluid Proteome Resource (CSF-PR).
    Guldbrandsen A; Farag YM; Lereim RR; Berven FS; Barsnes H
    Methods Mol Biol; 2019; 2044():377-391. PubMed ID: 31432427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset.
    Chiasserini D; van Weering JR; Piersma SR; Pham TV; Malekzadeh A; Teunissen CE; de Wit H; Jiménez CR
    J Proteomics; 2014 Jun; 106():191-204. PubMed ID: 24769233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Label-free analysis of human cerebrospinal fluid addressing various normalization strategies and revealing protein groups affected by multiple sclerosis.
    Opsahl JA; Vaudel M; Guldbrandsen A; Aasebø E; Van Pesch V; Franciotta D; Myhr KM; Barsnes H; Berle M; Torkildsen Ø; Kroksveen AC; Berven FS
    Proteomics; 2016 Apr; 16(7):1154-65. PubMed ID: 26841090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Versatile Workflow for Cerebrospinal Fluid Proteomic Analysis with Mass Spectrometry: A Matter of Choice between Deep Coverage and Sample Throughput.
    Macron C; Núñez Galindo A; Cominetti O; Dayon L
    Methods Mol Biol; 2019; 2044():129-154. PubMed ID: 31432411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioinformatics to Tackle the Biological Meaning of Human Cerebrospinal Fluid Proteome.
    Trindade F; Nogueira-Ferreira R; Bastos P; Amado F; Ferreira R; Vitorino R
    Methods Mol Biol; 2019; 2044():393-553. PubMed ID: 31432428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Label-Free LC-MS/MS Proteomic Analysis of Cerebrospinal Fluid Identifies Protein/Pathway Alterations and Candidate Biomarkers for Amyotrophic Lateral Sclerosis.
    Collins MA; An J; Hood BL; Conrads TP; Bowser RP
    J Proteome Res; 2015 Nov; 14(11):4486-501. PubMed ID: 26401960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deep Dive on the Proteome of Human Cerebrospinal Fluid: A Valuable Data Resource for Biomarker Discovery and Missing Protein Identification.
    Macron C; Lane L; Núñez Galindo A; Dayon L
    J Proteome Res; 2018 Dec; 17(12):4113-4126. PubMed ID: 30124047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of human cerebrospinal fluid for proteomics biomarker analysis.
    Waybright TJ
    Methods Mol Biol; 2013; 1002():61-70. PubMed ID: 23625394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of individual mouse cerebrospinal fluid proteomes.
    Smith JS; Angel TE; Chavkin C; Orton DJ; Moore RJ; Smith RD
    Proteomics; 2014 May; 14(9):1102-6. PubMed ID: 24677814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deployment of Label-Free Quantitative Olfactory Proteomics to Detect Cerebrospinal Fluid Biomarker Candidates in Synucleinopathies.
    Lachén-Montes M; González-Morales A; Fernández-Irigoyen J; Santamaría E
    Methods Mol Biol; 2019; 2044():273-289. PubMed ID: 31432419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human CSF pain proteome.
    Khoonsari PE; Ossipova E; Lengqvist J; Svensson CI; Kosek E; Kadetoff D; Jakobsson PJ; Kultima K; Lampa J
    J Proteomics; 2019 Jan; 190():67-76. PubMed ID: 29852297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Top-Down Proteomics Applied to Human Cerebrospinal Fluid.
    Gay M; Sánchez-Jiménez E; Villarreal L; Vilanova M; Huguet R; Arauz-Garofalo G; Díaz-Lobo M; López-Ferrer D; Vilaseca M
    Methods Mol Biol; 2019; 2044():193-219. PubMed ID: 31432414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An integrated workflow for multiplex CSF proteomics and peptidomics-identification of candidate cerebrospinal fluid biomarkers of Alzheimer's disease.
    Hölttä M; Minthon L; Hansson O; Holmén-Larsson J; Pike I; Ward M; Kuhn K; Rüetschi U; Zetterberg H; Blennow K; Gobom J
    J Proteome Res; 2015 Feb; 14(2):654-63. PubMed ID: 25490617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomics analysis of human cerebrospinal fluid.
    Yuan X; Desiderio DM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 815(1-2):179-89. PubMed ID: 15652808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative proteomics of cerebrospinal fluid reveals a predictive model for differential diagnosis of pneumococcal, meningococcal, and enteroviral meningitis, and novel putative therapeutic targets.
    Cordeiro AP; Silva Pereira RA; Chapeaurouge A; Coimbra CS; Perales J; Oliveira G; Sanchez Candiani TM; Coimbra RS
    BMC Genomics; 2015; 16 Suppl 5(Suppl 5):S11. PubMed ID: 26040285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analyzing Cerebrospinal Fluid Proteomes to Characterize Central Nervous System Disorders: A Highly Automated Mass Spectrometry-Based Pipeline for Biomarker Discovery.
    Núñez Galindo A; Macron C; Cominetti O; Dayon L
    Methods Mol Biol; 2019; 1959():89-112. PubMed ID: 30852817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased Neuro-Axonal Proteins in CSF at First Attack of Suspected Multiple Sclerosis.
    Stoop MP; Runia TF; Stingl C; van der Vuurst de Vries RM; Luider TM; Hintzen RQ
    Proteomics Clin Appl; 2017 Dec; 11(11-12):. PubMed ID: 28941200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomic signatures of neuroinflammation in Alzheimer's disease, multiple sclerosis and ischemic stroke.
    Thygesen C; Larsen MR; Finsen B
    Expert Rev Proteomics; 2019 Jul; 16(7):601-611. PubMed ID: 31220951
    [No Abstract]   [Full Text] [Related]  

  • 20. Combined tissue and fluid proteomics with Tandem Mass Tags to identify low-abundance protein biomarkers of disease in peripheral body fluid: An Alzheimer's Disease case study.
    Russell CL; Heslegrave A; Mitra V; Zetterberg H; Pocock JM; Ward MA; Pike I
    Rapid Commun Mass Spectrom; 2017 Jan; 31(2):153-159. PubMed ID: 27813239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.